JP2013527760A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013527760A5 JP2013527760A5 JP2013508445A JP2013508445A JP2013527760A5 JP 2013527760 A5 JP2013527760 A5 JP 2013527760A5 JP 2013508445 A JP2013508445 A JP 2013508445A JP 2013508445 A JP2013508445 A JP 2013508445A JP 2013527760 A5 JP2013527760 A5 JP 2013527760A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- antigen
- lentiviral
- vsv
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10290238.4A EP2385107B1 (en) | 2010-05-03 | 2010-05-03 | Lentiviral vector based immunological compounds against malaria |
| EP10290238.4 | 2010-05-03 | ||
| PCT/EP2011/056887 WO2011138251A1 (en) | 2010-05-03 | 2011-04-29 | Lentiviral vector based immunological compounds against malaria |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015233691A Division JP2016041076A (ja) | 2010-05-03 | 2015-11-30 | レンチウイルスベクターに基づくマラリアに対する免疫学的化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013527760A JP2013527760A (ja) | 2013-07-04 |
| JP2013527760A5 true JP2013527760A5 (enExample) | 2013-08-15 |
| JP5937574B2 JP5937574B2 (ja) | 2016-06-22 |
Family
ID=42731903
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013508445A Active JP5937574B2 (ja) | 2010-05-03 | 2011-04-29 | レンチウイルスベクターに基づくマラリアに対する免疫学的化合物 |
| JP2015233691A Pending JP2016041076A (ja) | 2010-05-03 | 2015-11-30 | レンチウイルスベクターに基づくマラリアに対する免疫学的化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015233691A Pending JP2016041076A (ja) | 2010-05-03 | 2015-11-30 | レンチウイルスベクターに基づくマラリアに対する免疫学的化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9109234B2 (enExample) |
| EP (2) | EP2385107B1 (enExample) |
| JP (2) | JP5937574B2 (enExample) |
| KR (1) | KR20130096164A (enExample) |
| CN (1) | CN103314104B (enExample) |
| DK (1) | DK2385107T3 (enExample) |
| WO (1) | WO2011138251A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
| CN103965320A (zh) * | 2013-01-29 | 2014-08-06 | 苏州偲聚生物材料有限公司 | 多肽、包含该多肽的检测器件和检测试剂盒 |
| CA2913854A1 (en) | 2013-06-03 | 2014-12-11 | Theravectys | Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream promoter sequence |
| EP2878674A1 (en) * | 2013-11-28 | 2015-06-03 | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) | Stable episomes based on non-integrative lentiviral vectors |
| EP3087188A1 (en) | 2013-12-23 | 2016-11-02 | Theravectys | Lyophilized lentiviral vector particles, compositions and methods |
| US10010607B2 (en) | 2014-09-16 | 2018-07-03 | Institut Curie | Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune response |
| CN106290840A (zh) * | 2015-05-13 | 2017-01-04 | 上海凯创生物技术有限公司 | 间日疟原虫乳胶法检测试剂盒 |
| CN105754962A (zh) * | 2016-01-07 | 2016-07-13 | 中南大学 | 一种单循环复制艾滋病毒样颗粒及其制备方法和应用 |
| CN108779473A (zh) | 2016-03-16 | 2018-11-09 | 法国居里学院 | 用于制备具有环二核苷酸的病毒颗粒的方法和所述颗粒用于治疗癌症的用途 |
| KR20190044587A (ko) | 2016-05-19 | 2019-04-30 | 아메드 에스.아이. 앨리 | 합성 말라리아 면역원, 이의 조합, 및 말라리아 감염을 예방하고 치료하기 위한 이의 용도 |
| WO2018029256A1 (en) | 2016-08-09 | 2018-02-15 | Aarhus Universitet | Modulation of ifi16 and sting activity |
| EP3357504A1 (en) * | 2017-02-02 | 2018-08-08 | Institut Pasteur | Functional screening of antigenic polypeptides - use for the identification of antigens eliciting a protective immune response and for the selection of antigens with optimal protective activity |
| EP3357506A1 (en) * | 2017-02-02 | 2018-08-08 | Institut Pasteur | Multiple malaria pre-erythrocytic antigens and their use in the elicitation of a protective immune response in a host |
| CN109251929A (zh) * | 2018-04-27 | 2019-01-22 | 杭州贝英福生物科技有限公司 | 一种干扰二化螟几丁质酶基因CsCht10的siRNA |
| EP3796931A1 (en) | 2018-05-23 | 2021-03-31 | Institut Pasteur | Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host |
| WO2020014013A1 (en) * | 2018-07-09 | 2020-01-16 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Viral-vectored vaccine for malaria |
| CN109022456B (zh) * | 2018-07-24 | 2021-03-02 | 江南大学 | 一种表达卵形疟原虫ama1蛋白的病毒疫苗的制备方法 |
| GB201906283D0 (en) * | 2019-05-03 | 2019-06-19 | Moredun Res Institute | Vector |
| EP4208175A4 (en) * | 2020-09-01 | 2025-05-07 | The Trustees of The University of Pennsylvania | IMPROVED GENERATION OF T-CELL TRANSDUCING LENTIVIRAL VECTORS USING A COCAL ENVELOPE |
| US12304929B2 (en) * | 2021-04-12 | 2025-05-20 | Sk Bioscience Co., Ltd. | Recombinant RSV live vaccine strain and the preparing method thereof |
| EP4326321A1 (en) | 2021-04-20 | 2024-02-28 | Institut Curie | Compositions and methods for use in immunotherapy |
| EP4326769A1 (en) | 2021-04-20 | 2024-02-28 | Institut Curie | Compositions and methods for use in immunotherapy |
| CN116987157B (zh) * | 2023-09-27 | 2023-11-28 | 深圳华大生命科学研究院 | 一种弹状病毒包膜蛋白、含其的靶向慢病毒载体及其应用 |
| CN121005787B (zh) * | 2025-10-22 | 2025-12-26 | 南京鸿明生物科技有限公司 | 一种嵌合型包膜糖蛋白、其制备方法及涉及该包膜糖蛋白的包膜质粒、包装方法和试剂盒 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5766597A (en) * | 1991-03-07 | 1998-06-16 | Virogenetics Corporation | Malaria recombinant poxviruses |
| FR2777909B1 (fr) | 1998-04-24 | 2002-08-02 | Pasteur Institut | Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex |
| EP2169073B1 (en) | 1999-10-11 | 2013-11-13 | Institut Pasteur | Vector for the preparation of immunotherapeutical compositions |
| WO2001027304A2 (en) | 1999-10-12 | 2001-04-19 | Institut Pasteur | Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| DK200201741A (da) | 2002-11-12 | 2003-09-16 | Statens Seruminstitut | Vaccine comprising chimeric malaria proteins derived from Plasmodium falciparum |
| WO2004055187A1 (en) | 2002-12-17 | 2004-07-01 | Crucell Holland B.V. | Recombinant viral-based malaria vaccines |
| FR2872170B1 (fr) | 2004-06-25 | 2006-11-10 | Centre Nat Rech Scient Cnrse | Lentivirus non interactif et non replicatif, preparation et utilisations |
| US8158413B2 (en) | 2005-10-17 | 2012-04-17 | Institut Pasteur | Lentiviral vector-based vaccine |
| AU2006284756B2 (en) | 2005-08-31 | 2012-06-07 | Genvec, Inc. | Adenoviral vector-based malaria vaccines |
| WO2007095201A2 (en) * | 2006-02-15 | 2007-08-23 | The Regents Of The University Of California | Pseudotyped retroviral vectors and methods of use thereof |
| CA2695433C (en) | 2007-08-03 | 2025-05-06 | Institut Pasteur | Antiviral gene transfer vectors and their medicinal applications |
| AU2008288508B2 (en) * | 2007-08-13 | 2014-05-01 | Glaxosmithkline Biologicals S.A. | Vaccines |
-
2010
- 2010-05-03 EP EP10290238.4A patent/EP2385107B1/en active Active
- 2010-05-03 DK DK10290238.4T patent/DK2385107T3/en active
-
2011
- 2011-04-29 US US13/695,683 patent/US9109234B2/en active Active
- 2011-04-29 CN CN201180027852.4A patent/CN103314104B/zh active Active
- 2011-04-29 KR KR1020127031691A patent/KR20130096164A/ko not_active Withdrawn
- 2011-04-29 WO PCT/EP2011/056887 patent/WO2011138251A1/en not_active Ceased
- 2011-04-29 EP EP11716434A patent/EP2566956A1/en not_active Withdrawn
- 2011-04-29 JP JP2013508445A patent/JP5937574B2/ja active Active
-
2015
- 2015-07-15 US US14/799,633 patent/US9822153B2/en active Active
- 2015-11-30 JP JP2015233691A patent/JP2016041076A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9109234B2 (en) | Lentiviral vector based immunological compounds against malaria | |
| CN102482329B (zh) | 用辛德毕斯病毒包膜糖蛋白假型化的慢病毒载体 | |
| EP2676676B1 (en) | Recombinant viral vectors | |
| ES2963179T3 (es) | Vacunas contra el virus de la hepatitis b (VHB) y usos de las mismas | |
| Coutant et al. | A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria | |
| US12329808B2 (en) | Compositions and methods for generating an immune response to treat or prevent malaria | |
| MD3390430T2 (ro) | Antigenele virusului imunodeficienței umane, vectori, compoziții și metode de utilizare ale acestora | |
| CN102046785A (zh) | 基于慢病毒的免疫原性载体 | |
| Yusuf et al. | Adeno-associated virus as an effective malaria booster vaccine following adenovirus priming | |
| Limbach et al. | Viral vectors in malaria vaccine development | |
| Raska et al. | Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responses | |
| Reeder et al. | Strategic variants of CSP delivered as SynDNA vaccines demonstrate heterogeneity of immunogenicity and protection from Plasmodium infection in a murine model | |
| CN101394868A (zh) | 重组腺病毒5型/35型和痘病毒mva活病毒载体疫苗的联用诱导强大的免疫应答的方法 | |
| Schuldt et al. | Vaccine platforms combining circumsporozoite protein and potent immune modulators, rEA or EAT-2, paradoxically result in opposing immune responses | |
| Sun et al. | Vesicular stomatitis virus-based vaccine targeting plasmodium blood-stage antigens elicits immune response and protects against malaria with protein booster strategy | |
| JP2022536850A (ja) | Ｂ型肝炎ウイルス（ｈｂｖ）ワクチンおよび抗ｐｄ－１または抗ｐｄ－ｌ１抗体の組合せ | |
| JP2022537324A (ja) | Ｂ型肝炎ウイルス（ｈｂｖ）ワクチンおよび抗ｐｄ－１抗体の組合せ | |
| Peng et al. | Pseudotyped single-cycle simian immunodeficiency viruses expressing gamma interferon augment T-cell priming responses in vitro | |
| Kumar et al. | mRNA-LNP expressing PfCSP and Pfs25, two leading vaccine candidates targeting infection and transmission of Plasmodium falciparum | |
| Xu et al. | vaccine targeting plasmodium blood-stage antigens elicits immune response and protects against malaria with protein | |
| Halbroth et al. | Salman | |
| WO2014176530A1 (en) | Vaccination methods | |
| Shahin et al. | Heterologous prime-boost immunisation regimens against infectious diseases | |
| Biswas et al. | malaria sporozoite challenge in a murine model Kunitaka Yoshida1, 2, Mitsuhiro Iyori1, Andrew M. Blagborough3, Ahmed M. Salman 4, 5, Pawan Dulal4, Katarzyna A. Sala3, Daisuke S. Yamamoto 6, Shahid M. Khan5, Chris J. Janse5 | |
| EA045279B1 (ru) | Вакцины против вируса гепатита b (hbv) и их применение |